Image

Early Outcomes of MAKO Medial Unicompartmental Knee Arthroplasty

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

To determine if robotically-assisted UKA results in more consistent and improved component positioning and better patient reported outcome scores compared to manual TKA and MAKO TKA.

Description

The purpose of this study is to determine the early clinical and radiographic outcomes of robotically-assisted medial unicompartmental knee arthroplasty (mUKA) with the MAKO surgical robot using the Restoris MCK Partial Implant System. The primary end point will be the mean weekly VAS pain score during the first four weeks postoperatively. The results of this study may be compared to those of previously studied cohorts of patients from this institution who underwent manual total knee arthroplasty (TKA) with the Triathlon Knee System as well as robotically-assisted total knee arthroplasty with the MAKO surgical robot using the Triathlon Knee System

Eligibility

Inclusion Criteria:

  1. Unilateral primary medial unicompartmental knee arthroplasty
  2. Age 18 years of age or older
  3. Willing to sign informed consent
  4. Willing to return for all follow-up visits
  5. Smartphone or tablet device capable of running the FocusMotion platform

Exclusion Criteria:

  1. BMI > 40
  2. Personal history of DVT or PE
  3. Inflammatory arthritis
  4. Peripheral vascular disease
  5. Opioid use greater than 5 days per week
  6. Nonsteroidal anti-inflammatory allergy
  7. Walking aid for musculoskeletal or neurologic issue other than operative joint
  8. Bilateral medial unicompartmental knee arthroplasty
  9. Patient with an active infection or suspected infection in the operative joint
  10. The absolute and relative contraindications stated in the FDA cleared labeling for the device

Study details

Knee Osteoarthritis

NCT05736601

Washington University School of Medicine

28 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.